Patent Expiry
MRK: BELSOMRA: recorded patent 11980623 expiry
May 29, 2033 · SUVOREXANT. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- May 29, 2033
- Company
- Merck & Co., Inc. (MRK)
- Drug
- SUVOREXANT
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Patent Expiry
BELSOMRA: recorded patent 11980623 expiry
Orange Book application NDA204569, product 001, listed patent 11980623 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source
- Company
- Merck & Co., Inc. (MRK)
- Drug
- SUVOREXANT